Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson’s disease

References

• Aarsland, D., Bronnick, K., Larsen, J. P., Tysnes, O. B., Alves, G., & Norwegian ParkWest Study Group. (2009). Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest study. Neurology, 72(13), 1121–1126. https://doi.org/10.1212/01.wnl.0000338632.00552.cb
   PubMed Web of Science ®Google Scholar
• Bahar-Fuchs, A., Martyr, A., Goh, A. M., Sabates, J., & Clare, L. (2019). Cognitive training for people with mild to moderate dementia. The Cochrane Database of Systematic Reviews, 3(3), CD013069. https://doi.org/10.1002/14651858.CD013069.pub2
   Google Scholar
• Barbosa, R. P., Mendonca, M. D., Caetano, A. P., Lampreia, T. M., Miguel, R., & Bugalho, P. M. (2019). Cognitive complaints in Parkinson’s disease patients: From subjective cognitive complaints to dementia and affective disorders. Journal of Neural Transmission, 126(10), 1329–1335. https://doi.org/10.1007/s00702-019-02042-8
   PubMed Web of Science ®Google Scholar
• Bayram, E., Kaplan, N., Shan, G., & Caldwell, J. Z. K. (2020). The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson’s Disease. Aging, Neuropsychology, and Cognition, 27(4), 581–594. https://doi.org/10.1080/13825585.2019.1653445
   PubMed Web of Science ®Google Scholar
• Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins verbal learning test – Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12(1), 43–55. https://doi.org/10.1076/clin.12.1.43.1726
   Web of Science ®Google Scholar
• Benton, A. L., Sivan, A. B., Hamsher, K., Varney, N. R., & Spreen, O. (1994). Contributions to neuropsychological assessment: A clinical manual. Oxford University Press.
   Google Scholar
• Bezdicek, O., Nikolai, T., Michalec, J., Ruzicka, F., Havrankova, P., Roth, J., Růžička, E., & Jech, R. (2017). The diagnostic accuracy of Parkinson’s disease mild cognitive impairment battery using the movement disorder society task force criteria. Movement Disorders Clinical Practice, 4(2), 237–244. https://doi.org/10.1002/mdc3.12391
   PubMed Web of Science ®Google Scholar
• Cholerton, B., Johnson, C. O., Fish, B., Quinn, J. F., Chung, K. A., Peterson-Hiller, A. L., Rosenthal, L. S., Dawson, T. M., Albert, M. S., Hu, S.-C., Mata, I. F., Leverenz, J. B., Poston, K. L., Montine, T. J., Zabetian, C. P., & Edwards, K. L. (2018). Sex differences in progression to mild cognitive impairment and dementia in Parkinson’s disease. Parkinsonism & Related Disorders, 50, 29–36. https://doi.org/10.1016/j.parkreldis.2018.02.007
   PubMed Web of Science ®Google Scholar
• Cholerton, B., Weiner, M. W., Nosheny, R. L., Poston, K. L., Mackin, R. S., Tian, L., Ashford, J. W., & Montine, T. J. (2019). Cognitive performance in parkinson’s disease in the brain health registry. Journal of Alzheimer’s Disease, 68(3), 1029–1038. https://doi.org/10.3233/JAD-181009
   PubMed Web of Science ®Google Scholar
• Cholerton, B. A., Zabetian, C. P., Quinn, J. F., Chung, K. A., Peterson, A., Espay, A. J., Revilla, F. J., Devoto, J., Watson, G. S., Hu, S.-C., Edwards, K. L., Montine, T. J., & Leverenz, J. B. (2013). Pacific Northwest Udall Center of excellence clinical consortium: Study design and baseline cohort characteristics. Journal of Parkinson’s Disease, 3(2), 205–214. https://doi.org/10.3233/JPD-130189
   PubMedGoogle Scholar
• Curtis, A. F., Masellis, M., Camicioli, R., Davidson, H., & Tierney, M. C. (2019). Cognitive profile of non-demented Parkinson’s disease: Meta-analysis of domain and sex-specific deficits. Parkinsonism & Related Disorders, 60, 32–42. https://doi.org/10.1016/j.parkreldis.2018.10.014
   PubMed Web of Science ®Google Scholar
• Dadgar, H., Khatoonabadi, A. R., & Bakhtiyari, J. (2013). Verbal fluency performance in patients with non-demented Parkinson’s disease. Iranian Journal of Psychiatry, 8(1), 55–58. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655231/
   PubMedGoogle Scholar
• Davis, M. Y., Johnson, C. O., Leverenz, J. B., Weintraub, D., Trojanowski, J. Q., Chen-Plotkin, A., Van Deerlin, V. M., Quinn, J. F., Chung, K. A., Peterson-Hiller, A. L., Rosenthal, L. S., Dawson, T. M., Albert, M. S., Goldman, J. G., Stebbins, G. T., Bernard, B., Wszolek, Z. K., Ross, O. A., Dickson, D. W., Eidelberg, D., Mattis, P. J., Niethammer, M., Yearout, D., Hu, S.-C., Cholerton, B. A., Smith, M., Mata, I. F., Montin, T. J., Edwards, K. L., & Zabetian, C. P. (2016). Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurology, 73(10), 1217–1224. https://doi.org/10.1001/jamaneurol.2016.2245
   PubMed Web of Science ®Google Scholar
• De Roy, J., Postuma, R. B., Brillon-Corbeil, M., Montplaisir, J., Genier Marchand, D., Escudier, F., Panisset, M., Chouinard, S., & Gagnon, J. F. (2020). Detecting the cognitive prodrome of dementia in Parkinson’s disease. Journal of Parkinson’s Disease, 10(3), 1033–1046. https://doi.org/10.3233/JPD-191857
   PubMedGoogle Scholar
• Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Anthony Broe, G., Cummings, J., Dickson, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., & Dubois, B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707. quiz 1837. https://doi.org/10.1002/mds.21507.
   PubMed Web of Science ®Google Scholar
• Fine, E. M., Delis, D. C., Paul, B. M., & Filoteo, J. V. (2011). Reduced verbal fluency for proper names in nondemented patients with Parkinson’s disease: A quantitative and qualitative analysis. Journal of Clinical and Experimental Neuropsychology, 33(2), 226–233. https://doi.org/10.1080/13803395.2010.507185
   PubMed Web of Science ®Google Scholar
• Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 51(6), 745–752. https://doi.org/10.1136/jnnp.51.6.745
   PubMed Web of Science ®Google Scholar
• Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez-Martin, P., & Movement Disorder Society UPDRS Revision Task Force. (2008). Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129–2170. https://doi.org/10.1002/mds.22340
   PubMed Web of Science ®Google Scholar
• Goldman, J. G., & Sieg, E. (2020). Cognitive impairment and dementia in Parkinson disease. Clinics in Geriatric Medicine, 36(2), 365–377. https://doi.org/10.1016/j.cger.2020.01.001
   PubMed Web of Science ®Google Scholar
• Hassan, A., Wu, S. S., Schmidt, P., Malaty, I. A., Dai, Y. F., Miyasaki, J. M., & Okun, M. S. (2012). What are the issues facing Parkinson’s disease patients at ten years of disease and beyond?: Data from the NPF-QII study. Parkinsonism & Related Disorders, 18(Suppl 3), S10–14. https://doi.org/10.1016/j.parkreldis.2012.06.014
   PubMedGoogle Scholar
• Hely, M. A., Morris, J. G., Traficante, R., Reid, W. G., O’Sullivan, D. J., & Williamson, P. M. (1999). The Sydney multicentre study of Parkinson’s disease: Progression and mortality at 10 years. Journal of Neurology, Neurosurgery & Psychiatry, 67(3), 300–307. https://doi.org/10.1136/jnnp.67.3.300
   PubMed Web of Science ®Google Scholar
• Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M., & Morris, J. G. (2008). The Sydney multicenter study of Parkinson’s disease: The inevitability of dementia at 20 years. Movement Disorders, 23(6), 837–844. https://doi.org/10.1002/mds.21956
   PubMed Web of Science ®Google Scholar
• Henry, J. D., & Crawford, J. R. (2004). Verbal fluency deficits in Parkinson’s disease: A meta-analysis. Journal of the International Neuropsychological Society, 10(4), 608–622. https://doi.org/10.1017/S1355617704104141
   PubMed Web of Science ®Google Scholar
• Holthoff, V. A., Marschner, K., Scharf, M., Steding, J., Meyer, S., Koch, R., Donix, M., & Quinn, T. J. (2015). Effects of physical activity training in patients with Alzheimer’s dementia: Results of a pilot RCT study. PLoS One, 10(4), e0121478. https://doi.org/10.1371/journal.pone.0121478
   PubMed Web of Science ®Google Scholar
• Kelly, M. E., Duff, H., Kelly, S., McHugh Power, J. E., Brennan, S., Lawlor, B. A., & Loughrey, D. G. (2017). The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: A systematic review. Systematic Reviews, 6(1), 259. https://doi.org/10.1186/s13643-017-0632-2
   PubMed Web of Science ®Google Scholar
• Koerts, J., Meijer, H. A., Colman, K. S., Tucha, L., Lange, K. W., & Tucha, O. (2013). What is measured with verbal fluency tests in Parkinson’s disease patients at different stages of the disease? Journal of Neural Transmission, 120(3), 403–411. https://doi.org/10.1007/s00702-012-0885-9
   PubMed Web of Science ®Google Scholar
• Kudlicka, A., Clare, L., & Hindle, J. V. (2011). Executive functions in Parkinson’s disease: Systematic review and meta-analysis. Movement Disorders, 26(13), 2305–2315. https://doi.org/10.1002/mds.23868
   PubMed Web of Science ®Google Scholar
• Lanni, K. E., Ross, J. M., Higginson, C. I., Dressler, E. M., Sigvardt, K. A., Zhang, L., Malhado-Chang, N., & Disbrow, E. A. (2014). Perceived and performance-based executive dysfunction in Parkinson’s disease. Journal of Clinical and Experimental Neuropsychology, 36(4), 342–355. https://doi.org/10.1080/13803395.2014.892059
   PubMed Web of Science ®Google Scholar
• Litvan, I., Goldman, J. G., Troster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams-Gray, C. H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M. C., Burn, D. J., Barker, R. A., & Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement disorder society task force guidelines. Movement Disorders, 27(3), 349–356. https://doi.org/10.1002/mds.24893
   PubMed Web of Science ®Google Scholar
• Magnin, E., Sagawa, Y., Moulin, T., & Decavel, P. (2020). What are the minimal detectable changes in SDMT and verbal fluency tests for assessing changes in cognitive performance in persons with multiple sclerosis and non-multiple sclerosis controls? European Neurology, 83(3), 263–270. https://doi.org/10.1159/000508607
   PubMed Web of Science ®Google Scholar
• Martinez-Martin, P., Rodriguez-Blazquez, C., Mario, A., Arakaki, T., Arillo, V. C., Chana, P., Fernández, W., Garretto, N., Martínez-Castrillo, J. C., Rodríguez-Violante, M., Serrano-Dueñas, M., Ballesteros, D., Rojo-Abuin, J. M., Chaudhuri, K. R. & Merello, M. (2015). Parkinson’s disease severity levels and MDS-unified Parkinson’s disease rating scale. Parkinsonism & Related Disorders, 21(1), 50–54. https://doi.org/10.1016/j.parkreldis.2014.10.026
   PubMed Web of Science ®Google Scholar
• Mata, I. F., Leverenz, J. B., Weintraub, D., Trojanowski, J. Q., Chen-Plotkin, A., Van Deerlin, V. M., Ritz, B., Rausch, R., Factor, S. A., Wood-Siverio, C., Quinn, J. F., Chung, K. A., Peterson-Hiller, A. L., Goldman, J. G., Stebbins, G. T., Bernard, B., Espay, A. J., Revilla, F. J., Devoto, J., Rosenthal, L. S., Dawson, T. M., Albert, M. S., Tsuang, D., Huston, H., Yearout, D., Hu, S.-C., Cholerton, B. A., Montine, T. J., Edwards, K. L., & Zabetian, C. P. (2016). GBA variants are associated with a distinct pattern of cognitive deficits in Parkinson’s disease. Movement Disorders, 31(1), 95–102. https://doi.org/10.1002/mds.26359
   PubMed Web of Science ®Google Scholar
• Mata, I. F., Leverenz, J. B., Weintraub, D., Trojanowski, J. Q., Hurtig, H. I., Van Deerlin, V. M., Ritz, B., Rausch, R., Rhodes, S. L., Factor, S. A., Wood-Siverio, C., Quinn, J. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., Devoto, J., Hu, S.-C., Cholerton, B. A., Wan, J. Y., Montine, T. J., Edwards, K. L., & Zabetian, C. P. (2014). APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurology, 71(11), 1405–1412. https://doi.org/10.1001/jamaneurol.2014.1455
   PubMed Web of Science ®Google Scholar
• McDowd, J., Hoffman, L., Rozek, E., Lyons, K. E., Pahwa, R., Burns, J., & Kemper, S. (2011). Understanding verbal fluency in healthy aging, Alzheimer’s disease, and Parkinson’s disease. Neuropsychology, 25(2), 210–225. https://doi.org/10.1037/a0021531
   PubMed Web of Science ®Google Scholar
• Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Nocera, J. R., McGregor, K. M., Hass, C. J., & Crosson, B. (2015). Spin exercise improves semantic fluency in previously sedentary older adults. Journal of Aging and Physical Activity, 23(1), 90–94. https://doi.org/10.1123/japa.2013-0107
   PubMed Web of Science ®Google Scholar
• Obeso, I., Casabona, E., Bringas, M. L., Alvarez, L., & Jahanshahi, M. (2012). Semantic and phonemic verbal fluency in Parkinson’s disease: Influence of clinical and demographic variables. Behavioural Neurology, 25(2), 111–118. https://doi.org/10.1155/2012/673610
   PubMed Web of Science ®Google Scholar
• Paris, A. P., Saleta, H. G., De la Cruz Crespo Maraver, M., Silvestre, E., Freixa, M. G., Torrellas, C. P., Pont, S. A., Nadal, M. F., Garcia, S. A., Perea Bartolomé, M. V., Fernández, V. L. & Bayes, A. R. (2011). Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease. Movement Disorders, 26(7), 1251–1258. https://doi.org/10.1002/mds.23688
   PubMed Web of Science ®Google Scholar
• Pereira, J. B., Junque, C., Marti, M. J., Ramirez-Ruiz, B., Bartres-Faz, D., & Tolosa, E. (2009). Structural brain correlates of verbal fluency in Parkinson’s disease. Neuroreport, 20(8), 741–744. https://doi.org/10.1097/WNR.0b013e328329370b
   PubMed Web of Science ®Google Scholar
• Phongpreecha, T., Cholerton, B., Mata, I. F., Zabetian, C. P., Poston, K. L., Aghaeepour, N., Tian, L., Quinn, J. F., Chung, K. A., Hiller, A. L., Hu, S.-C., Edwards, K. L., & Montine, T. J. (2020). Multivariate prediction of dementia in Parkinson’s disease. NPJ Parkinson’s Disease, 6(1), 20. https://doi.org/10.1038/s41531-020-00121-2
   PubMed Web of Science ®Google Scholar
• Piatt, A. L., Fields, J. A., Paolo, A. M., Koller, W. C., & Troster, A. I. (1999). Lexical, semantic, and action verbal fluency in Parkinson’s disease with and without dementia. Journal of Clinical and Experimental Neuropsychology, 21(4), 435–443. https://doi.org/10.1076/jcen.21.4.435.885
   PubMed Web of Science ®Google Scholar
• Picco, A., Morbelli, S., Piccardo, A., Arnaldi, D., Girtler, N., Brugnolo, A., Bossert, I., Marinelli, L., Castaldi, A., De Carli, F., Campus, C., Abbruzzese, G., & Nobili, F. (2015). Brain (18)F-DOPA PET and cognition in de novo Parkinson’s disease. European Journal of Nuclear Medicine and Molecular Imaging, 42(7), 1062–1070. https://doi.org/10.1007/s00259-015-3039-0
   PubMed Web of Science ®Google Scholar
• Ramirez-Ruiz, B., Junque, C., Marti, M.-J., Valldeoriola, F., & Tolosa, E. (2006). Neuropsychological deficits in Parkinson’s disease patients with visual hallucinations. Movement Disorders, 21(9), 1483–1487. https://doi.org/10.1002/mds.20965
   PubMed Web of Science ®Google Scholar
• Rosenthal, L. S., Salnikova, Y. A., Pontone, G. M., Pantelyat, A., Mills, K. A., Dorsey, E. R., Wang, J., Wu, S. S., & Mari, Z. (2017). Changes in verbal fluency in Parkinson’s disease. Movement Disorders Clinical Practice, 4(1), 84–89. https://doi.org/10.1002/mdc3.12421
   PubMed Web of Science ®Google Scholar
• Santangelo, G., Trojano, L., Vitale, C., Ianniciello, M., Amboni, M., Grossi, D., & Barone, P. (2007). A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations. Movement Disorders, 22(16), 2418–2425. https://doi.org/10.1002/mds.21746
   PubMed Web of Science ®Google Scholar
• Sawamoto, N., Honda, M., Hanakawa, T., Aso, T., Inoue, M., Toyoda, H., Ishizu, K., Fukuyama, H., & Shibasaki, H. (2007). Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum. Neurology, 68(13), 1062–1068. https://doi.org/10.1212/01.wnl.0000257821.28992.db
   PubMed Web of Science ®Google Scholar
• Scholtissen, B., Dijkstra, J., Reithler, J., & Leentjens, A. F. (2006). Verbal fluency in Parkinson’s disease: Results of a 2-min fluency test. Acta Neuropsychiatrica, 18(1), 38–41. https://doi.org/10.1111/j.0924-2708.2006.00122.x
   PubMed Web of Science ®Google Scholar
• Skorvanek, M., Martinez-Martin, P., Kovacs, N., Rodriguez-Violante, M., Corvol, J.-C., Taba, P., Seppi, K., Levin, O., Schrag, A., Foltynie, T., Alvarez-Sanchez, M., Arakaki, T., Aschermann, Z., Aviles-Olmos, I., Benchetrit, E., Benoit, C., Bergareche-Yarza, A., Cervantes-Arriaga, A., Chade, A., Cormier, F., Datieva, V., Gallagher, D. A., Garretto, N., Gdovinova, Z., Gershanik, O., Grofik, M., Han, V., Huang, J., Kadastik-Eerme, L., Kurtis, M. M., Mangone, G., Martinez-Castrillo, J. C., Mendoza-Rodriguez, A., Minar, M., Moore, H. P., Muldmaa, M., Mueller, C., Pinter, B., Poewe, W., Rallmann, K., Reiter, E., Rodriguez-Blazquez, C., Singer, C., Tilley, B. C., Valkovic, P., Goetz, C. G., & Stebbins, G. T. (2017). Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration. Movement Disorders Clinical Practice, 126(10), 536–544. https://doi.org/10.1007/s00702-019-02042-8
   Google Scholar
• Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary (3rd ed.). Oxford; New York: Oxford University Press.
   Google Scholar
• Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010). Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Movement Disorders, 25(15), 2649–2653. https://doi.org/10.1002/mds.23429
   PubMed Web of Science ®Google Scholar
• Tremblay, C., Monchi, O., Hudon, C., Macoir, J., & Monetta, L. (2012). Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson’s disease? Parkinson’s Disease, 2013, 308501. https://doi.org/10.3233/JPD-130189
   Google Scholar
• Troster, A. I., Stalp, L. D., Paolo, A. M., Fields, J. A., & Koller, W. C. (1995). Neuropsychological Impairment in Parkinson’s disease with and without depression. Archives of Neurology, 52(12), 1164–1169. https://doi.org/10.1001/archneur.1995.00540360042014
   PubMedGoogle Scholar
• Vriend, C., Van Balkom, T. D., Van Druningen, C., Klein, M., Van der Werf, Y. D., Berendse, H. W., & Van den Heuvel, O. A. (2020). Processing speed is related to striatal dopamine transporter availability in Parkinson’s disease. NeuroImage: Clinical, 26, 102257. https://doi.org/10.1016/j.nicl.2020.102257
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (1987). Wechsler adult intelligence scale-revised manual. The Psychological Corporation.
   Google Scholar
• Wechsler, D. (1997). WAiS-III® administration and scoring manual. The Psychological Corporation Harcourt Brace & Company.
   Google Scholar
• Weintraub, D., Simuni, T., Caspell-Garcia, C., Coffey, C., Lasch, S., Siderowf, A., & Parkinson’s Progression Markers Initiative. (2015). Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson’s disease. Movement Disorders, 30(7), 919–927. https://doi.org/10.1002/mds.26170
   PubMed Web of Science ®Google Scholar
• Williams-Gray, C. H., Foltynie, T., Brayne, C. E., Robbins, T. W., & Barker, R. A. (2007). Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain, 130(7), 1787–1798. https://doi.org/10.1093/brain/awm111
   PubMed Web of Science ®Google Scholar
• Wilson, H., Pagano, G., Yousaf, T., Polychronis, S., De Micco, R., Giordano, B., Niccolini, F., & Politis, M. (2020). Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1). Journal of Neural Transmission, 127(1), 51–59. https://doi.org/10.1007/s00702-019-02125-6
   PubMed Web of Science ®Google Scholar
• Yan, Y. Y., Lei, K., Li, Y. Y., Liu, X. F., & Chang, Y. (2019). The correlation between possible RBD and cognitive function in Parkinson’s disease patients in China. Annals of Clinical and Translational Neurology, 23(15), 848–853. https://doi.org/10.1002/acn3.747
   Google Scholar
• Yarnall, A. J., Breen, D. P., Duncan, G. W., Khoo, T. K., Coleman, S. Y., Firbank, M. J., Nombela, C., Winder-Rhodes, S., Evans, J. R., Rowe, J. B., Mollenhauer, B., Kruse, N., Hudson, G., Chinnery, P. F., O’Brien, J. T., Robbins, T. W., Wesnes, K., Brooks, D. J., Barker, R. A., Burn, D. J., & ICICLE-PD Study Group. (2014). Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD study. Neurology, 82(4), 308–316. https://doi.org/10.1212/WNL.0000000000000066
   PubMed Web of Science ®Google Scholar
• Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 23(6), 37–49. https://doi.org/10.1002/mds.21956
   Google Scholar
• Zabetian, C. P., Yamamoto, M., Lopez, A. N., Ujike, H., Mata, I. F., Izumi, Y., Kaji, R., Maruyama, H., Morino, H., Oda, M., Hutter, C. M., Edwards, K. L., Schellenberg, G. D., Tsuang, D. W., Yearout, D., Larson, E. B., & Kawakami, H. (2009). LRRK2 mutations and risk variants in Japanese patients with Parkinson’s disease. Movement Disorders, 6(1), 1034–1041. https://doi.org/10.1186/s13643-017-0632-2
   Google Scholar